Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC

Get up to date on the optimal care of patients with squamous NSCLC by reviewing this downloadable slideset developed by Edward Kim, MD, and Mark A. Socinski, MD, with an accompanying expert-led Webcast and FAQ modules.
Edward S. Kim, MD
Program Director
Mark A. Socinski, MD
Program Director
person default
Paul K. Paik, MD
Nathan Pennell, MD, PhD
Rathi Pillai, MD
Thomas Stinchcombe, MD

Downloadable Slideset

In this downloadable slideset from the CCO Squamous NSCLC live meeting series, Edward S. Kim, MD, and Mark A. Socinski, MD, highlight recent data informing the optimal care of patients with advanced squamous NSCLC.

Released: September 1, 2017

FAQ Modules

Expert faculty from the 2017-2018 CCO Local Live meeting series, “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC,” answer frequently asked questions about treating squamous NSCLC, including considerations for newly diagnosed disease in special populations, choice of second-line immunotherapy, and management of immune-related adverse events.

Edward S. Kim, MD
Program Director
Mark A. Socinski, MD
Program Director
person default Paul K. Paik, MD Nathan Pennell, MD, PhD Rathi Pillai, MD Thomas Stinchcombe, MD
Released: February 26, 2018

Expert faculty from the 2017-2018 CCO Local Live meeting series “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC” answer frequently asked questions about treating squamous NSCLC, including considerations regarding tumor mutational burden, optimal sequencing of therapy, and future directions.

Edward S. Kim, MD
Program Director
Mark A. Socinski, MD
Program Director
person default Paul K. Paik, MD Nathan Pennell, MD, PhD Thomas Stinchcombe, MD
Released: April 26, 2018

On-Demand Webcast

In this on-demand Webcast from the 2017 CCO squamous NSCLC live meeting series, Paul K. Paik, MD, provides expert perspective on the optimal treatment of patients with advanced squamous NSCLC including discussion of the most recent clinical data and emerging therapeutic strategies.

Edward S. Kim, MD
Program Director
Mark A. Socinski, MD
Program Director
person default Paul K. Paik, MD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: December 18, 2017 Expiration: December 17, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by an educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.
Celgene Corporation
Lilly

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?